Coronavirus (COVID-19)

This post examines characteristics of adolescents ages 12 to 15 across in the United States to inform COVID-19 vaccination efforts once they become eligible to receive a vaccine.

Parents’ Eagerness for Their Children to Get Vaccinated Mirrors Their Own Intentions, with 3 in 10 Ready to Vaccinate Their Children as Soon as It’s Available Most adults (56%) nationally say they have gotten at least one dose of a COVID-19 vaccine, and few (9%) say they haven’t but want…

Most adults nationally say they have gotten at least one dose of a COVID-19 vaccine, and few say they haven’t but want to do so right away, posing a new challenge for the nation’s vaccination efforts. The latest report also explores parents’ intentions for their kids, confidence in vaccines’ safety, and a variety of potential incentives and requirements to increase vaccination uptake.

As of April 19, COVID-19 vaccine eligibility opened up to adults in all states, leaving many to wonder when supply will surpass vaccine demand. A recent brief examined when COVID-19 vaccine supply might outstrip demand in the U.S. nationally, estimating that the U.S. will reach this point within a few…

This analysis examines overall COVID-19 vaccination levels and how the rate of vaccinations over the last week has changed at state-level and national level. There is significant variability by state in how many adults in the US have been vaccinated with at least one dose. Most states are also seeing a decline in the pace of vaccinations, indicating that they may be approaching the point when vaccine supply exceeds demand.

As India and other countries continue to grapple with major COVID-19 outbreaks even as cases decline in this country, there is increasing attention to the global role that could be played by the U.S. government.  This is particularly the case now that the U.S. will soon have enough COVID-19 vaccine…

This brief examines U.S. policy options for helping expand global access to COVID-19 vaccines, focusing on four main areas: in-kind donations of vaccine doses, additional funding for global access mechanisms like COVAX, helping expand global vaccine manufacturing, and relaxing or waiving intellectual property protections on vaccine technologies. We summarize what the administration has done to date in these areas and policy issues related to each.

The COVID-19 pandemic and recent elections are changing the national conversation around expanding health care coverage and reining in rising health care costs. President Biden campaigned on a platform of expanding access to public health coverage in ways that could change the role of employer-sponsored health insurance, which currently covers…

This analysis examines list prices for COVID-19 testing at the largest hospitals in every state and finds they range widely from $20 to $850. Federal law now requires private insurers to cover COVID-19 tests at no cost to the patient and provides funding for people without health insurance.

This data note analyzes federal Medicaid outlays before and during the COVID-19 pandemic. In the one year since the onset of the pandemic, federal Medicaid outlays totaled $500.8 billion and grew by 19.5%, compared to 6.3% growth in the one year before the pandemic.